Skip to main content
. 2023 Jan 16;24(2):1799. doi: 10.3390/ijms24021799
BLIS Basal-like triple-negative breast cancer
ccfDNAs Circulating cell-free DNAs
ccfNAs Circulating cell-free nucleic acids
cfDI Circulating cell-free DNA integrity
CTCs Circulating tumor cells
ctDNAs Circulating cell-free tumor DNAs
ctmiRNAs Circulating cell-free tumor microRNAs
ctmRNAs Circulating cell-free tumor messenger RNAs
ctNAs Circulating cell-free tumor nucleic acids
ctncRNAs Circulating cell-free tumor non-coding RNAs
ER+ Estrogen receptor-positive breast cancer
HER2+ HER2-positive breast cancer
HR+ Hormone receptor-positive breast cancer
IM Immuno modulatory triple-negative breast cancer
LAR Luminal androgen receptor triple-negative breast cancer
MAF Mutant allele frequencies
MES Mesenchymal-like triple-negative breast cancer
NAC Neo-adjuvant chemotherapy
PARPi PARP inhibitor
PR+ Progesterone receptor-positive breast cancer
TFx Tumor fraction of circulating cell-free DNA
TNBC Triple-negative breast cancer
tncRNAs Tumor non-coding RNAs
VAF Variant allele frequencies